BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6518138)

  • 1. A model for erythropoiesis in experimental chronic renal failure.
    Mason C; Thomas TH
    Br J Haematol; 1984 Dec; 58(4):729-40. PubMed ID: 6518138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietic action of dexamethasone on the anemia associated with an experimental chronic renal failure.
    Malgor LA; Barrios L; de Albarenque MV; Verges E; de Markowsky EE; Montiel E; Mussin SM
    Acta Physiol Pharmacol Latinoam; 1987; 37(3):365-76. PubMed ID: 3503475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing effects on erythrocyte sodium and potassium during the development of chronic renal failure with anaemia in rats.
    Thomas TH; Mason C; Illingworth KM
    Clin Sci (Lond); 1986 Dec; 71(6):639-46. PubMed ID: 3791865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects erythropoietin on experimental anemia in rats with chronic renal failure].
    Ling SS; Zhou Y; Sun WL; Zhu DC; Zhang HY; Tang GZ; Jin YF; Zhu JZ
    Yao Xue Xue Bao; 1992; 27(6):412-7. PubMed ID: 1442067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of parathyroid hormone in the anemia of chronic terminal renal dysfunction in dogs.
    Petrites-Murphy MB; Pierce KR; Lowry SR; Fisher JW
    Am J Vet Res; 1989 Nov; 50(11):1898-905. PubMed ID: 2619121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One year of rHuEPO therapy prolongs RBC survival and may stabilize RBC membranes despite natural progression of chronic renal failure to uremia and need for dialysis.
    Schwartz AB; Kelch B; Terzian L; Prior J; Kim KE; Pequinot E; Kahn SB
    ASAIO Trans; 1990; 36(3):M691-6. PubMed ID: 2252785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockage of the Na-K-ATPase signaling-mediated oxidant amplification loop elongates red blood cell half-life and ameliorates uremic anemia induced by 5/6th PNx in C57BL/6 mice.
    Liu J; Chaudhry M; Bai F; Chuang J; Chaudhry H; Al-Astal AY; Nie Y; Sollars V; Sodhi K; Seligman P; Shapiro JI
    Am J Physiol Renal Physiol; 2022 Jun; 322(6):F655-F666. PubMed ID: 35435001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease.
    McGonigle RJ; Boineau FG; Beckman B; Ohene-Frempong K; Lewy JE; Shadduck RK; Fisher JW
    J Lab Clin Med; 1985 Apr; 105(4):449-58. PubMed ID: 3981057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
    McGonigle RJ; Wallin JD; Husserl F; Deftos LJ; Rice JC; O'Neill WJ; Fisher JW
    J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of testosterone on the anaemia of terminal renal failure (author's transl)].
    Augustin HJ; Kapaun W; Kötter C
    Dtsch Med Wochenschr; 1973 Nov; 98(45):2119-22. PubMed ID: 4757967
    [No Abstract]   [Full Text] [Related]  

  • 11. Disorders of red blood cell production in uremia.
    Eschbach JW; Adamson JW; Cook JD
    Arch Intern Med; 1970 Nov; 126(5):812-5. PubMed ID: 5475703
    [No Abstract]   [Full Text] [Related]  

  • 12. Uraemia is necessary for erythropoietin-induced hypertension in rats.
    Poux JM; Lartigue M; Chaisemartin RA; Galen FX; Leroux-Robert C
    Clin Exp Pharmacol Physiol; 1995 Oct; 22(10):769-71. PubMed ID: 8575115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hematologic effect of androgen in uremic patients. Study of packed cell volume and erythropoietin responses.
    Fried W; Jonasson O; Lang G; Schwartz F
    Ann Intern Med; 1973 Dec; 79(6):823-7. PubMed ID: 4761909
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of erythropoietin in the anemia of renal insufficiency in man and in an experimental uremic rabbit model.
    Schulz E; Mödder B; Fisher JW
    Contrib Nephrol; 1978; 13():69-80. PubMed ID: 710140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo.
    Eschbach JW; Mladenovic J; Garcia JF; Wahl PW; Adamson JW
    J Clin Invest; 1984 Aug; 74(2):434-41. PubMed ID: 6746902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors which affect erythropoiesis in partially nephrectomized and sham-operated rats.
    Anagnostou A; Vercellotti G; Barone J; Fried W
    Blood; 1976 Sep; 48(3):425-33. PubMed ID: 953364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reticulocyte response after immediate withdrawal of recombinant human erythropoietin in chronic hemodialysis patients].
    Caramelo C; Soto C; Neira F; López MD; Jiménez S; Albalate M; de Oña R; Llamas P; Deudero JJ
    Nefrologia; 2004; 24(4):351-6. PubMed ID: 15455495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma erythropoietin levels in patients undergoing long-term hemodialysis.
    Raich PC; Korst DR
    Arch Pathol Lab Med; 1978 Feb; 102(2):73-5. PubMed ID: 579968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietic effects of triiodothyronine on the anemia of renal failure in rats: comparative studies with testosterone and erythropoietin.
    Malgor LA; Barrios L; de Albarenque ME; Verges E; de Markowsky EE; Montiel E; Mussin SM
    Exp Hematol; 1986 May; 14(4):250-6. PubMed ID: 3699108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of anemia and its relationship with renal function, blood pressure, and erythropoietin in rats with chronic kidney disease.
    Phillips JK; Boyd R; Krockenberger MB; Burgio G
    Vet Clin Pathol; 2015 Sep; 44(3):342-54. PubMed ID: 26292198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.